Lanreotide 120mg Effectiveness in Subjects With Pancreatic Neuroendocrine Tumours (PanNET) in Routine Clinical Practice.
- Status
- TERMINATED
- Phase
- N/A
Clinical Trials Related to Ipsen
Related studies linked through entity extraction aliases.
LAnreotide in Metastatic Pheochromocytoma / PARAganglioma (LAMPARA)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Cabozantinib as 2nd Line Treatment in Subjects With Locally Advanced or Metastatic Renal Cell Carcinoma (RCC) With a Clear-Cell Component Who Progressed After 1st Line Treatment With Checkpoint Inhibitors
- Status
- COMPLETED
- Phase
- PHASE2
Abobotulinumtoxina Efficacy in Post-Traumatic Headache
- Status
- COMPLETED
- Phase
- PHASE4
Study to Assess the Use of Lanreotide Autogel® 120 mg in Patients With Locally Advanced or Metastatic Gastroenteropancreatic Neuroendocrine Tumours (GEP-NETs) in Routine Clinical Practice
- Status
- WITHDRAWN
- Phase
- N/A
Dose Escalation and Dose Expansion Study of IPN60090 in Patients With Advanced Solid Tumours
- Status
- TERMINATED
- Phase
- PHASE1
Liposomal Irinotecan Plus 5-FU / LV Combined With Paricalcitol in Patients With Advanced Pancreatic Cancer Progressed on Gemcitabine-based Therapy
- Status
- COMPLETED
- Phase
- PHASE1
Liposomal Irinotecan in Combination With Oxaliplatin, Leucovorin, and 5-fluorouracil for Patients With Locally Advanced Pancreatic Carcinoma:
- Status
- COMPLETED
- Phase
- PHASE2
Validation of Patient Reported Outcome Measures for Use in Hallux Valgus
- Status
- COMPLETED
- Phase
- N/A
Phase Ib/II Trial of Nal-Irinotecan and Nivolumab as Second-Line Treatment in Patients With Advanced Biliary Tract Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Post-marketing Surveillance on the Safety of CabometyxTM in Korean Patients
- Status
- COMPLETED
- Phase
- N/A
Evaluate the Safety, Tolerability, Biodistribution and Anti Tumour Activity of 177LU-OPS201 With Companion Imaging 68Ga-OPS202 PET/CT in Previously Treated Subjects With Locally Advanced or Metastatic Cancers Expressing Somatostatin Receptor 2 (SSTR2)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Validation of Patient Reported Outcome Measures for Use in Vulvodynia
- Status
- COMPLETED
- Phase
- N/A
Cabozantinib Real-life Use for Advanced Renal Cell Carcinoma in France: a Retrospective Descriptive Non-interventional Study of 2 Cohorts.
- Status
- COMPLETED
- Phase
- N/A
MM-398 and Ramucirumab in Treating Patients With Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Liposomal Irinotecan, Fluorouracil and Leucovorin in Treating Patients With Refractory Advanced High Grade Neuroendocrine Cancer of Gastrointestinal, Unknown, or Pancreatic Origin
- Status
- TERMINATED
- Phase
- PHASE2
Cabozantinib in Advanced Salivary Gland Cancer Patients
- Status
- TERMINATED
- Phase
- PHASE2
Pharmaco-Economic Study of Treatment Options in Patients With Advanced RCC
- Status
- COMPLETED
- Phase
- N/A
Define the Optimal Uptake Time of 68Ga-OPS202 When Used as a PET (Positron Emission Tomography) Imaging Agent in Subjects With Newly Diagnosed Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Non-interventional Retrospective Study to Describe Early Clinical Experience With Cabozantinib in Patients With Advanced Renal Cell Carcinoma (RCC) in the UK
- Status
- COMPLETED
- Phase
- N/A